Page 7 - Punit Dhillon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Skye Bioscience Closes Sale of Subsidiary, VerdÃ©lite Sciences, to C3 Souvenir Holding, with USD$5 60M Closing Payment

Skye Bioscience Closes Sale of Subsidiary, VerdÃ©lite Sciences, to C3 Souvenir Holding, with USD$5 60M Closing Payment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Saint eustacheSan diegoUnited statesDavid hydeSkye bioscienceAndrew kainPunit dhillonAdvisory servicesSkye bioscience incSciences incExchange commissionCalifornia newsfile corpEmerald health therapeutics incHyde advisory investments incSouvenir holding incWall street

Skye Bioscience marks SBI-100 clinical trial progress with new clinical research organization

Skye Bioscience CEO Punit Dhillon joins Natalie Stoberman from the Proactive studio to share the latest progress on its SBI-100 Ophthalmic Emulsion clinical.

Skye bioscienceNatalie stobermanPunit dhillon

Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion

Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSkye biosciencePunit dhillonExchange commissionSkye bioscience incUs drug enforcement agencyCalifornia newsfile corpWall streetEnforcement agencyControlled substances actInvestigational new drugRisk factors

Skye Bioscience Inc obtains central IRB approval for Phase 2 clinical trial with SBI-100 Ophthalmic Emulsion

Skye Bioscience Inc obtains central IRB approval for Phase 2 clinical trial with SBI-100 Ophthalmic Emulsion
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Skye biosciencePunit dhillonUs drug enforcement agencySkye bioscience incInvestigational new drugEnforcement agencyControlled substances

Skye Bioscience announces glaucoma treatment receives FDA authorization for new drug application

Skye Bioscience Chairman & CEO Punit Dhillon joins Natalie Stoberman from the Proactive newsroom to share the announcement of its SBI-100 OE glaucoma.

Skye bioscienceNatalie stobermanPunit dhillonSkye bioscience chairmanInvestigational new drug